Evidence map›Paper›PMID 37687252›Full record

ArticleMolecules (Basel, Switzerland)2023

Green Synthesis of Silver Nanoparticles Derived from

Polat İpek, Reşit Yıldız, Mehmet Fırat Baran, Abdulkerim Hatipoğlu, Ayşe Baran, Albert Sufianov, Ozal Beylerli

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Interpol review of forensic drug chemistry, 2022-2025.Forensic science international. Synergy · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Polat İpekDepartment of Physiology, Faculty of Veterinary Medicine, Dicle University, Diyarbakir 21280, Turkey.ORCID 0000-0003-1756-9757
Reşit YıldızDepartment of Nutrition and Dietetics, Faculty of Health Sciences, Mardin Artuklu University, Mardin 47200, Turkey.ORCID 0000-0001-5467-6821
Mehmet Fırat BaranDepartment of Food Processing, Vocational School of Technical Sciences, Batman University, Batman 72060, Turkey.ORCID 0000-0001-8133-6670
Abdulkerim HatipoğluDepartment of Nutrition and Dietetics, Faculty of Health Sciences, Mardin Artuklu University, Mardin 47200, Turkey.ORCID 0000-0002-1487-1953
Ayşe BaranDepartment of Biology, Graduate Education Institute, Mardin Artuklu University, Mardin 47200, Turkey.ORCID 0000-0002-2317-0489
Albert SufianovEducational and Scientific Institute of Neurosurgery, Peoples' Friendship University of Russia (RUDN University), Moscow 117198, Russia.ORCID 0000-0001-7580-0385
Ozal BeylerliCentral Research Laboratory, Bashkir State Medical University, Ufa 450008, Russia.ORCID 0000-0002-6149-5460

Funding

Dicle University VETERINARY.21.002.
6 · The paper itself

Abstract

In the last few decades, the search for metal nanoparticles as an alternative to cancer treatments and antibiotics has increased. In this article, the spectroscopic (ultraviolet-visible (UV-vis), electron-dispersing X-ray (EDX), and Fourier transform infrared (FT-IR)), microscopic (field emission scanning electron microscope (FE-SEM), transmission electron microscope (TEM), and atomic force microscope (AFM)), structural (X-ray diffractometer (XRD) and zetasizer), and analytic (thermogravimetric/differential thermal analyzer (TGA-DTA)) characterization of the silver nanoparticles (AgNPs) produced from

Indexed as

AdenocarcinomaAnti-Infective AgentsAntineoplastic AgentsColonic NeoplasmsMetal NanoparticlesPapaverCaco-2 CellsEscherichia coliHumansPlant ExtractsSilverSpectroscopy, Fourier Transform InfraredAnti-Infective AgentsAntineoplastic AgentsPlant ExtractsSilveranticancergreen synthesispathogen microorganismssilver nanoparticlesTEMXRD

Identifiers

PMID37687252
PMCPMC10489788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.